Anticancer agent 231

Anticancer agent 231 (Compound P5) is a tyrosine protein kinase inhibitor with a IC50 value of 3.95 μM. Anticancer agent 231 inhibits the cell viability, cell proliferation, cell migration and cancer dryness of triple negative breast cancer (TNBC) cells by targeting EGFR-ERK 1/2 signaling pathway, and is expected to play an important role in the field of TNBC disease therapy.

For research use only. We do not sell to patients.

  • CAS No.: 128519-30-2
  • Formula: C23H22ClN3
  • Molecular Weight:375.89
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs

All ERK Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00